News
Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients: Waltham, Massachusetts Wednesday, April 30, 2025, 1 ...
Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg: Our Bureau, Bengaluru Wednesday, April 30, 2025, 17:45 Hrs [I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback